IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM PAR
Total 13F shares
12,266,397
Share change
-23,508
Total reported value
$31,278,850
Price per share
$2.55
Number of holders
66
Value change
-$328,469
Number of buys
27
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q1 2019

As of 31 Mar 2019, IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,266,397 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, NATIXIS, STATE STREET CORP, Assenagon Asset Management S.A., Candriam Luxembourg S.C.A., GEODE CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 66 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.